Canada Intrathecal Pumps Market Size & Outlook, 2022-2030
Canada intrathecal pumps market, 2017-2030 (US$M)
Related Markets
Canada intrathecal pumps market highlights
- The Canada intrathecal pumps market generated a revenue of USD 26.2 million in 2022 and is expected to reach USD 35.4 million by 2030.
- The Canada market is expected to grow at a CAGR of 3.8% from 2023 to 2030.
- In terms of segment, morphine was the largest revenue generating type in 2022.
- Bupivacaine is the most lucrative type segment registering the fastest growth during the forecast period.
Intrathecal pumps market data book summary
| Market revenue in 2022 | USD 26.2 million |
| Market revenue in 2030 | USD 35.4 million |
| Growth rate | 3.8% (CAGR from 2022 to 2030) |
| Largest segment | Morphine |
| Fastest growing segment | Bupivacaine |
| Historical data | 2017 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Baclofen, Bupivacaine, Clonidine, Morphine, Ziconotide, Other Type |
| Key market players worldwide | Medtronic PLC, Smiths Group PLC, Teleflex Inc, Johnson & Johnson, Medallion Therapeutics, Tricumed Medical Technology, Arrow International Inc, Flowonix |
Other key industry trends
- In terms of revenue, Canada accounted for 7.7% of the global intrathecal pumps market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. intrathecal pumps market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 154.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Intrathecal Pumps Market Scope
Intrathecal Pumps Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Canada intrathecal pumps market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to intrathecal pumps market will help companies and investors design strategic landscapes.
Morphine was the largest segment with a revenue share of 30.92% in 2022. Horizon Databook has segmented the Canada intrathecal pumps market based on baclofen, bupivacaine, clonidine, morphine, ziconotide, other type covering the revenue growth of each sub-segment from 2017 to 2030.
Patients with chronic pain do not receive adequate relief from regular pain-relieving drugs and even morphine-like drugs. Therefore, targeted drug delivery system is required to provide patients relief from pain. Hence, pain-relieving drugs are given through an intrathecal pumps for direct delivery of drug to the targeted site.
The Canadian government is conducting assessment series to understand whether an intrathecal drug delivery system provides relief from pain or not after chronic disease management. In January 2016, as per the health technology assessment at Health Quality Ontario, intrathecal drug delivery systems help in reducing refractory or persistent chronic nonmalignant (noncancer) pain by 27% in comparison to oral opioid analgesia alone and morphine consumption.
Similarly, the assessment for Intrathecal BaclofenPumps for Spasticity has also being conducted by Medical Advisory Secretariat, part of the Ontario Ministry of Health and Long-Term Care under its Ontario Health Technology Assessment Series.
Reasons to subscribe to Canada intrathecal pumps market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Canada intrathecal pumps market databook
-
Our clientele includes a mix of intrathecal pumps market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada intrathecal pumps market, including forecasts for subscribers. This country databook contains high-level insights into Canada intrathecal pumps market from 2017 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Canada intrathecal pumps market size, by type, 2017-2030 (US$M)
Canada Intrathecal Pumps Market Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
